Combination Therapy for Chronic Hepatitis B: Current Indications
Author:
Publisher
Springer Science and Business Media LLC
Subject
Virology,Hepatology
Link
http://www.springerlink.com/index/pdf/10.1007/s11901-011-0095-1
Reference50 articles.
1. Wasley A, Kruszon-Moran D, Kuhnert W, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis. 2010;202:192–201.
2. • Kim WR. Epidemiology of hepatitis B in the United States. Hepatology. 2009;49:S28–34. This article provides a succinct review of the current epidemiologic trends of hepatitis B in the United States.
3. Sato K, Mori M. Current and novel therapies for hepatitis B virus infection. Mini Rev Med Chem. 2010;10:20–31.
4. •• Monto A, Schooley RT, Lai JC, et al. Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop. Am J Gastroenterol. 2010;105:989–1004. This article is the summary of a workshop on combination therapy for viral hepatitis. It provides a good overview of the theory behind trying combination therapy for hepatitis B.
5. •• Woo G, Tomlinson G, Nishikawa Y, et al. Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses. Gastroenterology. 2010;139:1218–29. This recent meta-analysis analyzes the various current therapeutic options for HBeAg-positive and HBeAg-negative hepatitis B, including some combinations.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of combination of therapies on chronic hepatitis B virus through resolution of an optimal control problem using comparative of direct method and Pontryagin's maximum principle;International Journal of Computing Science and Mathematics;2021
2. Combination therapy against human infections caused by viruses;Combination Therapy Against Multidrug Resistance;2020
3. HBV‐Pol is crucial for HBV‐mediated inhibition of inflammasome activation and IL‐1β production;Liver International;2019-08-30
4. Chronic hepatitis B virus and liver fibrosis: A mathematical model;PLOS ONE;2018-04-10
5. Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy;Immunology Letters;2017-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3